Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feraheme vs Venofer in Iron Deficiency Anemia
NCT01114204Phase 3Completed
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Start
- Aug 2010
- Primary completion
- Nov 2011
- Modality
- Nanoparticles, Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of ferumoxytol in iron deficiency anemia (IDA), sponsored by AMAG Pharmaceuticals, Inc.. Started Aug 2010; status: completed.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01114204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01114204.